Enabling successful digital pathology: Key factors for high-throughput routine diagnosis
There has been widespread adoption of digital pathology in a clinical environment over the past few years. Digital pathology holds many benefits for laboratories and patients including opportunities to drive workflow efficiencies to provide faster turnaround times for patient results, in particular for second opinions and referrals. In order to prepare the laboratory for digital pathology there are several factors that need to be addressed to ensure it is successful. This webinar discusses those key factors in detail, the importance in getting them right first time, showcases the Leica Biosystems Aperio GT 450 DX designed to scale up digital pathology for high-throughput routine diagnosis and how Leica Biosystems can support implementation.
Key learning objectives
- The best approach for enabling successful digital pathology in the laboratory
- Key success factors to prepare for digital pathology
- How Leica can support laboratories in their digital pathology journey
- Showcase the Aperio GT 450 DX
Who should attend?
- Lab Managers
- Pathologists
- Lab Technicians
- IT Managers
Certificate of attendance
All webinar participants can request from SelectScience a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
For In Vitro Diagnostic Use.
The clinical use claims described in the information provided have not been cleared or approved by the U.S. FDA or are not available in the United States.
Copyright © 2022 Leica Biosystems Imaging, Inc. All Rights Reserved. LEICA and the Leica logo are registered trademarks of Leica Microsystems IR GmbH. Aperio is a registered trademark of Leica Biosystems Imaging, Inc. in the USA and optionally in other countries. GT and GT 450 are trademarks of Leica Biosystems Imaging, Inc. in the USA and optionally in other countries. Other logos, product and/or company names might be trademarks of their respective owners.